Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.

ABSTRACT:

Objective

Telmisartan, an angiotensin II type 1 receptor blocker, and amlodipine, a calcium channel blocker, are antihypertensive agents clinically used as monotherapy or in combination. They exert beneficial cardiovascular effects independently of blood pressure lowering and classic mechanisms of action. In this study, we investigate molecular mechanisms responsible for the off-target effects of telmisartan and telmisartan-amlodipine in endothelial cells (ECs), using an unbiased genomic approach.

Approach and results

In human umbilical vein ECs, microarray analysis of gene expression followed by pathway enrichment analysis and quantitative polymerase chain reaction validation revealed that telmisartan modulates the expression of key genes responsible for cell cycle progress

SUBMITTER: Siragusa M 

PROVIDER: S-EPMC3818114 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature